Genetic Variants in the Host Restriction Factor APOBEC3G are Associated With HIV-1–Related Disease Progression and Central Nervous System Impairment in Children

Por Singh, Kumud K., Wang, Yan, Gray, Kathryn P., Farhad, Mona, Brummel, Sean, Fenton, Terence, Trout, Rodney, Spector, Stephen A.
Publicado em 2013

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0...

Por Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco
Publicado no Breast Cancer Res Treat (2016)

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

Por Ewertz, Marianne, Gray, Kathryn P., Regan, Meredith M., Ejlertsen, Bent, Price, Karen N., Thürlimann, Beat, Bonnefoi, Hervé, Forbes, John F., Paridaens, Robert J., Rabaglio, Manuela, Gelber, Richard D., Colleoni, Marco, Láng, István, Smith, Ian E., Coates, Alan S., Goldhirsch, Aron, Mouridsen, Henning T.
Publicado em 2012

Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers

Por Sieuwerts, Anieta M., Willis, Scooter, Burns, Michael B., Look, Maxime P., Gelder, Marion E. Meijer-Van, Schlicker, Andreas, Heideman, Marinus R., Jacobs, Heinz, Wessels, Lodewyk, Leyland-Jones, Brian, Gray, Kathryn P., Foekens, John A., Harris, Reuben S., Martens, John W. M.
Publicado no Horm Cancer (2014)

Prospective Analysis of Genetic Polymorphisms and Risk of Recurrence in Renal Cell Cancer

Por Schutz, Fabio A. B., Pomerantz, Mark M., Gray, Kathryn P., Atkins, Prof Michael B., Rosenberg, Jonathan E., Hirsch, Michelle S., McDermott, David F., Lampron, Megan E., Lee, Gwo-Shu Mary, Signoretti, Sabina, Kantoff, Prof Philip W., Freedman, Matthew L., Choueiri, Toni K.
Publicado em 2012

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

Por Johansson, Harriet, Gray, Kathryn P., Pagani, Olivia, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf, Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A.
Publicado no Breast Cancer Res (2016)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

Por Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Publicado em 2013

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of O...

Por Bellet, Meritxell, Gray, Kathryn P., Francis, Prudence A., Láng, István, Ciruelos, Eva, Lluch, Ana, Climent, Miguel Angel, Catalán, Gustavo, Avella, Antoni, Bohn, Uriel, González-Martin, Antonio, Ferrer, Roser, Catalán, Roberto, Azaro, Analía, Rajasekaran, Agnita, Morales, Josefa, Vázquez, Josep, Fleming, Gini F., Price, Karen N., Regan, Meredith M.
Publicado no J Clin Oncol (2016)

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Por Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Publicado no J Clin Oncol (2016)

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

Por Leyland-Jones, Brian, Gray, Kathryn P., Abramovitz, Mark, Bouzyk, Mark, Young, Brandon, Long, Bradley, Kammler, Roswitha, Dell’Orto, Patrizia, Biasi, Maria Olivia, Thürlimann, Beat, Harvey, Vernon, Neven, Patrick, Arnould, Laurent, Maibach, Rudolf, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Pagani, Olivia, Viale, Giuseppe, Rae, James M., Regan, Meredith M.
Publicado no Breast Cancer Res Treat (2015)

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Por Leyland-Jones, Brian, Gray, Kathryn P., Abramovitz, Mark, Bouzyk, Mark, Young, Brandon, Long, Bradley, Kammler, Roswitha, Dell'Orto, Patrizia, Biasi, Maria Olivia, Thürlimann, Beat, Lyng, Maria B., Ditzel, Henrik J., Harvey, Vernon J., Neven, Patrick, Treilleux, Isabelle, Rasmussen, Birgitte Bruun, Maibach, Rudolf, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Pagani, Olivia, Viale, Giuseppe, Rae, James M., Regan, Meredith M.
Publicado no Breast Cancer Res Treat (2015)

Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic Renal Cell Carcinoma

Por Kwiatkowski, David J., Choueiri, Toni K., Fay, André P., Rini, Brian I., Thorner, Aaron R., de Velasco, Guillermo, Tyburczy, Magdalena E., Hamieh, Lana, Albiges, Laurence, Agarwal, Neeraj, Ho, Thai H., Song, Jiaxi, Pignon, Jean-Christophe, Barrios, Pablo M., Michaelson, M. Dror, Van Allen, Eliezer, Krajewski, Katherine M., Porta, Camillo, Pal, Sumanta, Bellmunt, Joaquim, McDermott, David F., Heng, Daniel Y. C., Gray, Kathryn P., Signoretti, Sabina
Publicado no Clin Cancer Res (2016)